HealthcareServices

Revenue of the Albumin Market Predicted to Achieve $10.61 Billion by 2030, Driven by 8% CAGR

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the albumin market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Albumin Market?

The albumin market size has demonstrated significant expansion in recent years. It is anticipated to expand from $7.16 billion in 2025 to $7.81 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. The historical growth of this market is attributable to the constrained supply of plasma-derived albumin, an increase in the prevalence of liver diseases and burns, greater utilization in diagnostic kits, growing biopharmaceutical research and development activities, and its early integration into laboratory and research applications.

The albumin market is anticipated to experience robust expansion over the coming years. Its value is projected to reach $10.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This projected increase within the forecast period stems from progress in recombinant albumin technology, increasing requirements for personalized medicine, the broader application of albumin in drug delivery mechanisms, a rise in biopharmaceutical production, and heightened investment in both therapeutic and cosmetic uses. Key developments expected during this timeframe involve a surging need for human serum albumin in medical treatments, its increasing incorporation into drug formulations and vaccines, the widening scope of recombinant albumin’s utility in biopharma, greater uptake of albumin in cell culture and diagnostic kits, and a concentrated effort on albumin-centric research and customized medicine.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

What Drivers Are Supporting Technological Adoption In The Albumin Market?

The growing occurrence of diabetes is projected to fuel the expansion of the albumin market. This chronic metabolic condition is characterized by abnormally high blood glucose levels, which can lead to kidney issues such as diabetic nephropathy over time. A significant contributor to the increasing incidence of diabetes is the surge in obesity rates, with substantial epidemiological evidence demonstrating a strong link between higher body mass index levels and a considerably elevated diabetes risk. Albumin supports patient management by aiding in the monitoring of kidney function and guiding treatment strategies for diabetic individuals. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, diabetes impacted an estimated 589 million adults and 9.5 million people with type 1 diabetes in 2024, including 1.9 million children and adolescents, and the total number of individuals living with the disease is projected to rise to 853 million by 2050. Consequently, the increasing prevalence of diabetes is propelling the growth of the albumin market.

Which Segments Are Contributing To The Growth Of The Albumin Market?

The albumin market covered in this report is segmented –

1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin

2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications

3) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications

Which Trends Are Expected To Influence The Albumin Market In The Upcoming Years?

Leading companies within the albumin market are innovating offerings, including animal- and human-origin-free recombinant albumin, to provide enhanced functionalities to clients. This particular albumin is produced via non-mammalian expression systems, like yeast, and is entirely devoid of animal or human-derived ingredients. As an illustration, in March 2023, UK’s Albumedix, a recombinant human albumin (rHA) producer, joined forces with Japan’s Heartseed Inc., a clinical-stage biotech firm. Their collaboration aims to introduce Recombin, an essential excipient for Heartseed’s investigational cell therapy, HS-001, coinciding with the start of its initial human clinical trial. This partnership represents a crucial advancement for HS-001, a product anticipated to transform disease treatment. Incorporating Recombin into the manufacturing process guarantees optimal performance and stability for the cell therapy, thereby strengthening its prospects for therapeutic achievement.

Who Are The Core Companies Influencing Trends In The Albumin Market?

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Which Regions Are Projected To Dominate The Albumin Market In The Coming Years?

North America was the largest region in the albumin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Albumin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16333&type=smp

Browse Through More Reports Similar to the Global Albumin Market 2026, By The Business Research Company

Catalogue Market Report 2026

https://www.thebusinessresearchcompany.com/report/catalogue-global-market-report

Albumin Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Music Recording Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-recording-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795